Idorsia (OTCPK:IDRS.F) Update / briefing March 31, 2026 09:00 AM ET Company ParticipantsAlberto Gimona - Head of Global Clinical Development and Medical AffairsJean-Paul Clozel - Chairman of the Board and Interim CEOKevin Boss - Director of Investor RelationsMartine Clozel - Chief Scientific Officer and Head of ResearchSandrine van den Hurk - Equity Research AssociateConference Call ParticipantsJoris Zimmermann - Healthcare Research AnalystJustine Tellier - Equity Research AnalystRaghuram Selvaraju - Managi ...